Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

48.50
Delayed Data
As of Apr 20
 -0.35 / -0.72%
Today’s Change
29.95
Today|||52-Week Range
50.05
+21.71%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line19.9M14.0M91.2M57.3M
 
 
 
 
 
Depreciation928.0K921.0K2.4M8.1M
 
 
 
 
 
Total Other Cash Flow4.4M7.1M6.5M4.3M
 
 
 
 
 
Funds From Operations25.2M22.1M58.4M90.9M
 
 
 
 
 
Funds From/For Other Operating Expenses17.5M-10.1M-8.4M-23.7M
 
 
 
 
 
Net Cash Flow - Operating Activities7.7M32.1M66.8M114.6M
 
 
 
 
 
 
InvestingIncrease In Investments-53.3M-63.2M-47.4M-101.9M
 
 
 
 
 
Decrease In Investments53.5M37.6M31.8M28.7M
 
 
 
 
 
Capital Expenditures-593.0K-2.1M-1.6M-2.0M
 
 
 
 
 
Net Cash Flow Investing-4.9M-36.2M-36.0M-86.4M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.00------
Long Term Borrowings0.000.00------
Long Term Debt Reduction0.000.00------
Net Proceeds Stock Sale571.0K1.9M2.1M5.7M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing--0.000.000.00--
Other Uses - Financing1.0K0.000.000.00
 
 
Net Cash Flow - Financing570.0K1.9M2.1M5.7M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash3.4M-2.2M32.9M33.9M